BioLegend, Inc.
- Home
- Companies
- BioLegend, Inc.
- Products
- Alexa Fluor - Model 488 - Anti-Mouse ...
Alexa Fluor - Model 488 -Anti-Mouse IgD Antibody
FromBioLegend, Inc.
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 488 under optimal conditions.
Most popular related searches
- Isotype Control:Alexa Fluor® 488 Rat IgG2a, κ Isotype Ctrl
- Reactivity:Mouse
- Antibody Type:Monoclonal
- Host Species:Rat
- Formulation:Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation:The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 488 under optimal conditions.
- Concentration:0.5 mg/ml
- Storage & Handling:The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application:FC - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
* Alexa Fluor® 488 has a maximum emission of 519 nm when it is excited at 488 nm.
Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.
View full statement regarding label licenses - Excitation Laser: Blue Laser (488 nm)
- Application Notes:The 11-26c.2a antibody reacts with immunoglobulin D in all tested mouse haplotypes. The antibody binds membrane IgD expressed on most B cells. The 11-26c.2a antibody neither induces proliferation of splenic B cells nor induces B cell activation. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections2,3.
- Application References:
(PubMed link indicates BioLegend citation)
- Nitschke L, et al. 1993. P. Natl. Acad. Sci. USA 90:1887. (FC)
- Weih D, et al. 2001. J. Immunol. 167:1909. (IHC)
- Koni PA, et al. 2001. J. Exp. Med. 193:741. (IHC)
- Ahuja A, et al. 2007. J. Immunol. 179:3351. (FC) PubMed
- Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
- Good-Jacobson KL, et al. 2010. Nat. Immunol. 11:535. (FC) PubMed
- Tomayko MM, et al. 2010. J. Immunol. 185:7146. PubMed
- Park SY, et al. 2013. J. Immunol. 190:1094. PubMed
- Rouaud P, et al. 2014. J Exp Med. 211:975. PubMed
- Product Citations:
- Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
- Katsuyama T, et al. 2019. J Clin Invest. 129:5411. PubMed
- Sarapulov AV, et al. 2020. Front Immunol. 11:599. PubMed
- Béguelin W, et al. 2020. Cancer Cell. 37(5):655-673. PubMed
- Ly A, et al. 2020. Cell Reports. 29(8):2257-2269.e6.. PubMed
- Rouaud P, et al. 2014. J Exp Med. 211:975. PubMed
- RRID
- AB_10730618 (BioLegend Cat. No. 405717)
AB_10730619 (BioLegend Cat. No. 405718)
- Structure:Ig family
- Distribution:B cells
- Function:B cell differentiation
- Cell Type:B cells
- Biology Area:Immunology
- Gene ID:380797 View all products for this Gene ID
- UniProt:View information about IgD on UniProt.org
